REQUEST A DEMO
Total
USD $0.00
Search more companies

Emmes Biopharma Slovakia S.R.O. (Slovakia)

Main Activities: Other Business Support Services
Full name: Emmes Biopharma Slovakia S.R.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Emmes Biopharma Slovakia S.R.O. is an enterprise in Slovakia, with the main office in Kosice. The company operates in the Other Business Support Services industry. The company was established on May 23, 2008. The total number of employees is currently 25 - 49 (2023). In 2023, the company reported a net sales revenue increase of 41.6%. Over the same period, its total assets grew by 31.61%. The net profit margin of Emmes Biopharma Slovakia S.R.O. increased by 3.06% in 2023.

Headquarters
Pri nemocnici, 3
Kosice; Kosicky; Postal Code: 04001

Contact Details: Purchase the Emmes Biopharma Slovakia S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Emmes Biopharma Slovakia S.R.O. report to view the information.
Outstanding Shares:
Purchase the Emmes Biopharma Slovakia S.R.O. report to view the information.
Registered Capital:
Purchase the Emmes Biopharma Slovakia S.R.O. report to view the information.
Incorporation Date:
May 23, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
89.88%
Purchase this report to view the information.
10.12%
Company Performance
Financial values in the chart are available after Emmes Biopharma Slovakia S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
41.6%
Total operating revenue
41.47%
Operating profit (EBIT)
80.26%
EBITDA
86.62%
Net Profit (Loss) for the Period
82.7%
Total assets
31.61%
Total equity
45.14%
Operating Profit Margin (ROS)
3.77%
Net Profit Margin
3.06%
Return on Equity (ROE)
6.39%
Debt to Equity Ratio
-4.13%
Quick Ratio
1.07%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?